Abstract
The coronavirus disease 19 (COVID-19) is a highly pathogenic and transmissible viral disease caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which originated in the city of Wuhan, Hubei Province, Central China and spread quickly around the world. The genome sequence of SARSCoV- 2 is phylogenetically related to bat-derived severe acute respiratory syndrome-like (SARS-like) coronaviruses; therefore bats could be the possible primary reservoirs. At present, there are no clinically approved vaccines or specific antiviral drugs for COVID- 19. However, several broad-spectrum antiviral drugs have been evaluated against COVID-19 in clinical studies and resulted in the improvement of patients. In this regard, other therapies such as antiviral drugs, antibodies, stem cells and plasma therapy are being studied. In the current study, we reviewed the emergence, pathogenicity and the genome structure of COVID-19 infection. The main focus of this study is on the therapeutic approaches that may be effective against SARS-CoV-2.
Keywords: COVID-19, novel coronavirus, therapeutic, SARS-CoV-2, antiviral, SARS-CoV-19.
Current Molecular Medicine
Title:Therapeutic Measures for the Novel Coronavirus: A Review of Current Status and Future Perspective
Volume: 21 Issue: 7
Author(s): Mahshid Shahverdi and Maryam Darvish*
Affiliation:
- Department of Medical Biotechnology, School of Medicine, Arak University of Medical Sciences, Arak,Iran
Keywords: COVID-19, novel coronavirus, therapeutic, SARS-CoV-2, antiviral, SARS-CoV-19.
Abstract: The coronavirus disease 19 (COVID-19) is a highly pathogenic and transmissible viral disease caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which originated in the city of Wuhan, Hubei Province, Central China and spread quickly around the world. The genome sequence of SARSCoV- 2 is phylogenetically related to bat-derived severe acute respiratory syndrome-like (SARS-like) coronaviruses; therefore bats could be the possible primary reservoirs. At present, there are no clinically approved vaccines or specific antiviral drugs for COVID- 19. However, several broad-spectrum antiviral drugs have been evaluated against COVID-19 in clinical studies and resulted in the improvement of patients. In this regard, other therapies such as antiviral drugs, antibodies, stem cells and plasma therapy are being studied. In the current study, we reviewed the emergence, pathogenicity and the genome structure of COVID-19 infection. The main focus of this study is on the therapeutic approaches that may be effective against SARS-CoV-2.
Export Options
About this article
Cite this article as:
Shahverdi Mahshid and Darvish Maryam *, Therapeutic Measures for the Novel Coronavirus: A Review of Current Status and Future Perspective, Current Molecular Medicine 2021; 21 (7) . https://dx.doi.org/10.2174/1566524020666201203170230
DOI https://dx.doi.org/10.2174/1566524020666201203170230 |
Print ISSN 1566-5240 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5666 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Docking Screens: Right for the Right Reasons?
Current Topics in Medicinal Chemistry From Multiple PAR1 Receptor/Protein Interactions to their Multiple Therapeutic Implications
Current Topics in Medicinal Chemistry <i>Bis</i>-1,3,4-Oxadiazole Derivatives as Novel and Potential Urease Inhibitors; Synthesis, <i>In Vitro</i>, and <i>In Silico</i> Studies
Medicinal Chemistry Impact of Quaternary Structure Dynamics on Allosteric Drug Discovery
Current Topics in Medicinal Chemistry Cardiovascular Effects of Losartan and Its Relevant Clinical Application
Current Medicinal Chemistry Calpains: Attractive Targets for the Development of Synthetic Inhibitors
Current Topics in Medicinal Chemistry Phosphonamide-Based Metalloproteinase Inhibitors: A New Approach to the Development of Safer Metalloproteinase Inhibitors
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents Revisiting Antipsychotic-induced Akathisia: Current Issues and Prospective Challenges
Current Neuropharmacology Selective Glucocorticoid Receptor Ligands
Medicinal Chemistry The Janus Face of Adenosine: Antiarrhythmic and Proarrhythmic Actions
Current Pharmaceutical Design Codon Usage Biases in Alzheimers Disease and Other Neurodegenerative Diseases
Protein & Peptide Letters A Review on the Role of Transition Metals in Selenylation Reactions
Current Organic Synthesis Meet the Editorial Board Member
Current Drug Therapy Clinical Aspects of Melatonin in the Acute Coronary Syndrome
Current Vascular Pharmacology Viral Evolution will Automatically Resolve COVID-19 Pandemic
Combinatorial Chemistry & High Throughput Screening Regulating Clinical Trials in Saudi Arabia
Applied Clinical Research, Clinical Trials and Regulatory Affairs Pentacyclic Triterpenoids and Their Saponins with Apoptosis-Inducing Activity
Current Topics in Medicinal Chemistry Novel Spiro/non-Spiro Pyranopyrazoles: Eco-Friendly Synthesis, In-vitro Anticancer Activity, DNA Binding, and In-silico Docking Studies
Current Bioactive Compounds The Effects of Creatine Supplementation and Physical Exercise on Traumatic Brain Injury
Mini-Reviews in Medicinal Chemistry A Review of Intrahepatic Cholestasis of Pregnancy
Current Women`s Health Reviews